Potential uses of T3 in the treatment of human disease

Gross, 1952, The identification of 3:5:3′L-triiodothyronine in human plasma, Lancet, 1, 439, 10.1016/S0140-6736(52)91952-1 Pitt-Rivers, 1955, Conversion of thyroxine to 3-5-3′ triiodothyronine in vivo, J Clin Endocrinol Metab, 15, 616, 10.1210/jcem-15-5-616 Sterling, 1969, Determination of triiodothyronine concentration in human serum, J Clin Invest, 48, 1150, 10.1172/JCI106072 Hoffenberg, 1973, Triiodothyronine, Clin Endocrinol, 2, 75, 10.1111/j.1365-2265.1973.tb03487.x Klein, 2003, Evaluation of the therapeutic efficacy of different levothyroxine preparations in the treatment of human thyroid disease, Thyroid, 13, 1127, 10.1089/10507250360731523 Sawin, 1990, Thyroid hormone therapy: Origins and early history, Thyroid Today, 13, 1 White, 1893, The pharmacy of the thyroid gland, Pharmaceut J, 24, 194 Roti, 1993, The use and misuse of thyroid hormone, Endocrine Rev, 14, 401 Singer, 1995, Treatment guidelines for patients with hyperthyroidism and hypothyroidism, JAMA, 273, 808, 10.1001/jama.1995.03520340064038 Dillmann, 1990, Biochemical basis of thyroid hormone action in the heart, Am J Med, 88, 626, 10.1016/0002-9343(90)90530-Q Harvey, 2002, Mechanism of thyroid hormone action, Thyroid, 12, 441, 10.1089/105072502760143791 Xu, 1999, Coactivator and corepressor complexes in nuclear receptor function, Curr Opin Genet Dev, 9, 140, 10.1016/S0959-437X(99)80021-5 Davis, 2002, Nongenomic actions of thyroid hormone on the heart, Thyroid, 12, 459, 10.1089/105072502760143827 Danzi, 2003, Thyroid hormone and blood pressure regulation, Curr Hypertension Reports, 5, 513, 10.1007/s11906-003-0060-7 Danzi, 2003, Triiodothyronine-mediated myosin heavy chain gene transcription in the heart, Am J Physiol Heart Circ Physiol, 284, H2255, 10.1152/ajpheart.00860.2002 Saberi, 1974, Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy, J Clin Endocrinol Metab, 39, 923, 10.1210/jcem-39-5-923 Danzi, 2005, Effect of serum triiodothyronine on the regulation of cardiac gene expression: Role of histone acetylation, Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00182.2005 Chopra, 2000, Nature and sources of circulating thyroid hormones, 121 Demers, 2003, Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease, Thyroid, 13, 3, 10.1089/105072503321086962 Hollowell, 2002, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III), J Clin Endocrinol Metab, 87, 489, 10.1210/jc.87.2.489 Andersen, 2002, Narrow individual variations in serum T(4) and T(3) in normal subjects: A clue to the understanding of subclinical thyroid disease, J Clin Endocrinol Metab, 87, 1068, 10.1210/jc.87.3.1068 Escobar-Morreale, 1995, Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats, J Clin Invest, 96, 2828, 10.1172/JCI118353 Escobar-Morreale, 1996, Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat, Endocrinology, 137, 2490, 10.1210/en.137.6.2490 Escobar-Morreale, 1997, Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine, Endocrinology, 138, 2559, 10.1210/en.138.6.2559 St. Germain, 1994, Iodothyronine deiodinases, Trends Endocrinol Metab, 5, 36, 10.1016/1043-2760(94)90119-8 Leonard, 2000, Intracellular pathways of iodothyronine metabolism, 136 Peeters, 2005, A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters, Am J Physiol Endocrinol Metab, 289, E75, 10.1152/ajpendo.00571.2004 Franklyn, 1984, Thyroid status in patients after acute myocardial infarction, Clin Sci (Colch), 67, 585, 10.1042/cs0670585 Klemperer, 1996, Thyroid hormone therapy in cardiovascular disease, Prog Cardiovasc Dis, 38, 1, 10.1016/S0033-0620(96)80017-X De Groot, 1999, Dangerous dogmas in medicine: The non-thyroidal illness syndrome, J Clin Endocrinol Metab, 84, 151, 10.1210/jc.84.1.151 Hamilton, 1990, Altered hormone metabolism in advanced heart failure, J Am Coll Cardiol, 16, 91, 10.1016/0735-1097(90)90462-X Ascheim, 2002, Thyroid hormone metabolism in patients with congestive heart failure: The low triiodothyronine state, Thyroid, 6, 511, 10.1089/105072502760143908 Peeters, 2003, Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients, J Clin Endocrinol Metab, 88, 3202, 10.1210/jc.2002-022013 Smith, 1970, Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism, BMJ, 4, 145, 10.1136/bmj.4.5728.145 Bunevicius, 1999, Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism, N Engl J Med, 340, 424, 10.1056/NEJM199902113400603 Walsh, 2003, Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: A randomized controlled trial in patients with primary hypothyroidism, J Clin Endocrinol Metab, 88, 4543, 10.1210/jc.2003-030249 Sawka, 2003, Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial, J Clin Endocrinol Metab, 88, 4551, 10.1210/jc.2003-030139 Clyde, 2003, Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism, JAMA, 290, 2952, 10.1001/jama.290.22.2952 Siegmund, 2004, Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism, Clin Endocrinol, 60, 750, 10.1111/j.1365-2265.2004.02050.x Saravanan, 2005, Partial substitution of thyroxine (T4) with triiodothyronine in patients on T4 replacement therapy: Results of a large community-based randomized controlled trial, J Clin Endocrinol Metab, 90, 805, 10.1210/jc.2004-1672 Escobar-Morreale, 2005, Thyroid hormone replacement therapy in primary hypothyroidism: A randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone, Ann Intern Med, 142, 412, 10.7326/0003-4819-142-6-200503150-00007 Appelhof, 2005, Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: A double-blind, randomized, controlled clinical trial, J Clin Endocrinol Metab, 90, 2666, 10.1210/jc.2004-2111 Escobar-Morreale, 2005, Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine, J Clin Endocrinol Metab, 90, 4946, 10.1210/jc.2005-0184 Toft, 1999, Thyroid hormone replacement—one hormone or two?, New Engl J Med, 340, 468, 10.1056/NEJM199902113400611 Kaplan, 2003, In search of the impossible dream: Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients, J Clin Endocrinol Metab, 88, 4540, 10.1210/jc.2003-031436